330 related articles for article (PubMed ID: 26496025)
1. Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells.
Holzmann C; Kappel S; Kilch T; Jochum MM; Urban SK; Jung V; Stöckle M; Rother K; Greiner M; Peinelt C
Oncotarget; 2015 Dec; 6(39):41783-93. PubMed ID: 26496025
[TBL] [Abstract][Full Text] [Related]
2. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
4. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
[TBL] [Abstract][Full Text] [Related]
5. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
6. Expression of store-operated channel components in prostate cancer: the prognostic paradox.
Perrouin Verbe MA; Bruyere F; Rozet F; Vandier C; Fromont G
Hum Pathol; 2016 Mar; 49():77-82. PubMed ID: 26826413
[TBL] [Abstract][Full Text] [Related]
7. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
Hong X; Yu JJ
Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
[TBL] [Abstract][Full Text] [Related]
9. ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer.
Holzmann C; Kilch T; Kappel S; Armbrüster A; Jung V; Stöckle M; Bogeski I; Schwarz EC; Peinelt C
Oncotarget; 2013 Nov; 4(11):2096-107. PubMed ID: 24240085
[TBL] [Abstract][Full Text] [Related]
10. Small Molecular Inhibitors Block TRPM4 Currents in Prostate Cancer Cells, with Limited Impact on Cancer Hallmark Functions.
Borgström A; Hauert B; Kappel S; Zoni E; Kiener M; Stokłosa P; Baur R; Spahn M; Kruithof-de Julio M; Peinelt C
J Mol Biol; 2021 Aug; 433(17):166665. PubMed ID: 33058873
[TBL] [Abstract][Full Text] [Related]
11. TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.
Asuthkar S; Velpula KK; Elustondo PA; Demirkhanyan L; Zakharian E
Oncotarget; 2015 Jul; 6(19):17221-36. PubMed ID: 25980497
[TBL] [Abstract][Full Text] [Related]
12. p53 alters intracellular Ca
Kappel S; Ross-Kaschitza D; Hauert B; Rother K; Peinelt C
Cell Calcium; 2022 Jun; 104():102591. PubMed ID: 35500522
[TBL] [Abstract][Full Text] [Related]
13. TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.
Sun Y; Schaar A; Sukumaran P; Dhasarathy A; Singh BB
Mol Carcinog; 2018 Jun; 57(6):752-761. PubMed ID: 29500887
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
[TBL] [Abstract][Full Text] [Related]
15. TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells.
Sagredo AI; Sagredo EA; Cappelli C; Báez P; Andaur RE; Blanco C; Tapia JC; Echeverría C; Cerda O; Stutzin A; Simon F; Marcelain K; Armisén R
Mol Oncol; 2018 Feb; 12(2):151-165. PubMed ID: 28614631
[TBL] [Abstract][Full Text] [Related]
16. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
[TBL] [Abstract][Full Text] [Related]
17. TRPM4 in Cancer-A New Potential Drug Target.
Borgström A; Peinelt C; Stokłosa P
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562811
[TBL] [Abstract][Full Text] [Related]
18. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
19. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
20. TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.
Kappel S; Stokłosa P; Hauert B; Ross-Kaschitza D; Borgström A; Baur R; Galván JA; Zlobec I; Peinelt C
Mol Oncol; 2019 Nov; 13(11):2393-2405. PubMed ID: 31441200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
